Sunshine Biopharma, Inc. (SBFM)

Sunshine Biopharma Revenue

Sunshine Biopharma had revenue of $8.09M in the quarter ending March 31, 2026, a decrease of -9.13%. This brings the company's revenue in the last twelve months to $35.49M, down -2.05% year-over-year. In the year 2025, Sunshine Biopharma had annual revenue of $36.31M with 4.11% growth.

• Revenue (ttm): $35.49M
• Revenue Growth: -2.05%
• P/S Ratio: 0.10
• Revenue / Employee: $709,866
• Employees: 50
• Market Cap: 3.59M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	36.31M	1.43M	4.11%
Dec 31, 2024	34.87M	10.78M	44.75%
Dec 31, 2023	24.09M	19.75M	454.42%
Dec 31, 2022	4.35M	4.12M	1,802.41%
Dec 31, 2021	228.43K	157.02K	219.88%
Dec 31, 2020	71.41K	50.29K	238.10%
Dec 31, 2019	21.12K	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	1.71K	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-
Dec 31, 2011	-	-	-
Dec 31, 2010	-	-	-
Jul 31, 2009	-	-	-
Jul 31, 2008	-	-	-

Data Source: Fiscal.ai Last updated: May 13, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 12, 2026

Data Sources Report a data error